Shiyu Capital
Beijing, Beijingshiyucapital.com
Overview
Shiyu Capital is a professional private equity investment and asset management institution founded in September 2014. The firm is headquartered in Beijing with branches in Shanghai and Sanya, China. It focuses on equity investments in the pharmaceutical and healthcare industries, including areas like biotechnology, IVD (in-vitro diagnostics), medical services, and drug development. Shiyu Capital also provides asset allocation and wealth management services for high-net-worth families and institutional clients. Its flagship fund is the "Danqing innovative pharma industry fund".
Portfolio Companies
9
Website
shiyucapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| UP3D Tech | Dec 2021 | Series A | Lead |
| WuXi Diagnostics | Feb 2021 | Series B | Co-investor |
| Guangzhou KingCreate Biotechnology Co., Ltd. | Jul 2019 | Series A | Co-investor |
| Lepu Biopharma | Jul 2019 | Series A | Lead |
| Shanghai Lepure Biotech Co., Ltd. | Jul 2019 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
